tiprankstipranks
Trending News
More News >
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
Advertisement

Diamedica Therapeutics (DMAC) Similar Stocks

Compare
492 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Diamedica Therapeutics
$3.63
$155.67M
1.40%
3 Buy
0 Hold
0 Sell
Strong Buy
Protara Therapeutics
$3.05
$117.67M
28.15%
4 Buy
0 Hold
0 Sell
Strong Buy
Rezolute
$5.26
$456.65M
8.45%
6 Buy
0 Hold
0 Sell
Strong Buy
Fulcrum Therapeutics
$7.83
$422.66M
-7.34%
4 Buy
2 Hold
1 Sell
Moderate Buy
Tango Therapeutics
$5.93
$642.78M
-40.82%
3 Buy
0 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.85
$137.53M
24.16%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DMAC
Diamedica Therapeutics
3.63
0.05
1.40%
TARA
Protara Therapeutics
3.05
0.67
28.15%
RZLT
Rezolute
5.26
0.41
8.45%
FULC
Fulcrum Therapeutics
7.83
-0.62
-7.34%
TNGX
Tango Therapeutics
5.93
-4.09
-40.82%
IKT
Inhibikase Therapeutics
1.85
0.36
24.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis